163 related articles for article (PubMed ID: 28990534)
1. Association between Vitamin D Status, Oxidative Stress Biomarkers and Viral Load in Human Immunodeficiency Virus Type 1 Infection.
Flauzino T; Simao ANC; de Almeida ERD; Morimoto HK; Oliveira SR; Alfieri DF; Ueda LT; Dichi I; Reiche EMV
Curr HIV Res; 2017 Nov; 15(5):336-344. PubMed ID: 28990534
[TBL] [Abstract][Full Text] [Related]
2. Profile of oxidative stress markers is dependent on vitamin D levels in patients with chronic hepatitis C.
de Almeida JP; Liberatti LS; Barros FE; Kallaur AP; Lozovoy MA; Scavuzzi BM; Panis C; Reiche EM; Dichi I; Simão AN
Nutrition; 2016 Mar; 32(3):362-7. PubMed ID: 26847403
[TBL] [Abstract][Full Text] [Related]
3. Cross-sectional study of vitamin D levels, immunologic and virologic outcomes in HIV-infected adults.
Bearden A; Abad C; Gangnon R; Sosman JM; Binkley N; Safdar N
J Clin Endocrinol Metab; 2013 Apr; 98(4):1726-33. PubMed ID: 23457406
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D Insufficiency/Deficiency in HIV-Infected Inner City Youth.
Poowuttikul P; Thomas R; Hart B; Secord E
J Int Assoc Provid AIDS Care; 2014; 13(5):438-42. PubMed ID: 23881908
[TBL] [Abstract][Full Text] [Related]
5. Metabolic syndrome and the decreased levels of uric acid by leflunomide favor redox imbalance in patients with rheumatoid arthritis.
Costa NT; Scavuzzi BM; Iriyoda TMV; Lozovoy MAB; Alfieri DF; de Medeiros FA; de Sá MC; Micheletti PL; Sekiguchi BA; Reiche EMV; Maes M; Simão ANC; Dichi I
Clin Exp Med; 2018 Aug; 18(3):363-372. PubMed ID: 29644482
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D status and oxidative stress markers in the elderly with impaired fasting glucose and type 2 diabetes mellitus.
Gradinaru D; Borsa C; Ionescu C; Margina D; Prada GI; Jansen E
Aging Clin Exp Res; 2012 Dec; 24(6):595-602. PubMed ID: 22968324
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D deficiency is associated with disability and disease progression in multiple sclerosis patients independently of oxidative and nitrosative stress.
Oliveira SR; Simão ANC; Alfieri DF; Flauzino T; Kallaur AP; Mezzaroba L; Lozovoy MAB; Sabino BS; Ferreira KPZ; Pereira WLCJ; Kaimen-Maciel DR; Dichi I; Reiche EMV
J Neurol Sci; 2017 Oct; 381():213-219. PubMed ID: 28991684
[TBL] [Abstract][Full Text] [Related]
8. Daily Nutritional Supplementation with Vitamin D₃ and Phenylbutyrate to Treatment-Naïve HIV Patients Tested in a Randomized Placebo-Controlled Trial.
Ashenafi S; Amogne W; Kassa E; Gebreselassie N; Bekele A; Aseffa G; Getachew M; Aseffa A; Worku A; Hammar U; Bergman P; Aderaye G; Andersson J; Brighenti S
Nutrients; 2019 Jan; 11(1):. PubMed ID: 30634590
[TBL] [Abstract][Full Text] [Related]
9. Retinal microangiopathy in human immunodeficiency virus infection is related to higher human immunodeficiency virus-1 load in plasma.
Furrer H; Barloggio A; Egger M; Garweg JG;
Ophthalmology; 2003 Feb; 110(2):432-6. PubMed ID: 12578793
[TBL] [Abstract][Full Text] [Related]
10. Risk Factors of Hypovitaminosis D in HIV-Infected Patients on Suppressive Antiretroviral Therapy.
Mikuła T; Sapuła M; Suchacz MM; Kozłowska J; Krankowska D; Stańczak W; Wiercińska-Drapało A
AIDS Res Hum Retroviruses; 2020 Aug; 36(8):676-680. PubMed ID: 32408752
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D status in a Brazilian cohort of adolescents and young adults with perinatally acquired human immunodeficiency virus infection.
Schtscherbyna A; Gouveia C; Pinheiro MF; Luiz RR; Farias ML; Machado ES
Mem Inst Oswaldo Cruz; 2016 Feb; 111(2):128-33. PubMed ID: 26872341
[TBL] [Abstract][Full Text] [Related]
12. Predictors of virological outcome and safety in primary HIV type 1-infected patients initiating quadruple antiretroviral therapy: QUEST GW PROB3005.
Hoen B; Cooper DA; Lampe FC; Perrin L; Clumeck N; Phillips AN; Goh LE; Lindback S; Sereni D; Gazzard B; Montaner J; Stellbrink HJ; Lazzarin A; Ponscarme D; Staszewski S; Mathiesen L; Smith D; Finlayson R; Weber R; Wegmann L; Janossy G; Kinloch-de Loes S;
Clin Infect Dis; 2007 Aug; 45(3):381-90. PubMed ID: 17599319
[TBL] [Abstract][Full Text] [Related]
13. Vitamin-D deficiency impairs CD4+T-cell count recovery rate in HIV-positive adults on highly active antiretroviral therapy: A longitudinal study.
Ezeamama AE; Guwatudde D; Wang M; Bagenda D; Kyeyune R; Sudfeld C; Manabe YC; Fawzi WW
Clin Nutr; 2016 Oct; 35(5):1110-7. PubMed ID: 26371397
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with vitamin D deficiency in a population of 2044 HIV-infected patients.
Theodorou M; Sersté T; Van Gossum M; Dewit S
Clin Nutr; 2014 Apr; 33(2):274-9. PubMed ID: 23680190
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of vitamin D deficiency in HIV-positive, antiretroviral treatment-naïve patients in a single centre study.
Gedela K; Edwards SG; Benn P; Grant AD
Int J STD AIDS; 2014 Jun; 25(7):488-92. PubMed ID: 24352123
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D Levels and Markers of Inflammation and Metabolism in HIV-Infected Individuals on Suppressive Antiretroviral Therapy.
Hoffman RM; Lake JE; Wilhalme HM; Tseng CH; Currier JS
AIDS Res Hum Retroviruses; 2016 Mar; 32(3):247-54. PubMed ID: 26569649
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus load and immune activation in human immunodeficiency virus type 1-infected patients.
Petrara MR; Cattelan AM; Zanchetta M; Sasset L; Freguja R; Gianesin K; Cecchetto MG; Carmona F; De Rossi A
J Clin Virol; 2012 Mar; 53(3):195-200. PubMed ID: 22209290
[TBL] [Abstract][Full Text] [Related]
18. Higher vitamin D levels in HIV-infected out-patients on treatment with boosted protease inhibitor monotherapy.
Cervero M; Agud JL; Torres R; García-Lacalle C; Alcázar V; Jusdado JJ; Moreno S
HIV Med; 2013 Oct; 14(9):556-62. PubMed ID: 23738846
[TBL] [Abstract][Full Text] [Related]
19. Human immunodeficiency virus type-1 (HIV-1) disease progression and viral activity: a seroepidemiological and molecular study.
Bukhari SZ; Qazi JI; Ashshi AM; Zia N
J Coll Physicians Surg Pak; 2012 Sep; 22(9):565-9. PubMed ID: 22980609
[TBL] [Abstract][Full Text] [Related]
20. Residual low-level viral replication could explain discrepancies between viral load and CD4+ cell response in human immunodeficiency virus-infected patients receiving antiretroviral therapy.
García F; Vidal C; Plana M; Cruceta A; Gallart MT; Pumarola T; Miro JM; Gatell JM
Clin Infect Dis; 2000 Feb; 30(2):392-4. PubMed ID: 10671348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
